ClassID:

94823

C07D285/08 - CPC Classification

Classification description:

Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups  - ; Five-membered rings; Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings 1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles

Recent Application in this class:
#1
20260132114
2026-05-14

METHOD FOR PRODUCING 3-METHYL-1,2,4-THIADIAZOLE-5-CARBOHYDRAZIDE

#2
20260132106
2026-05-14

FABP4/5 INHIBITORS, METHODS OF USE AND METHODS OF MAKING

#3
20260116862
2026-04-30

NOVEL METHOD FOR PRODUCING 3-METHYL-1,2,4-THIADIAZOLE-5-CARBOHYDRAZIDE

#4
20260015345
2026-01-15

ROUTE FOR CONSTRUCTING CHIRAL FRAGMENT OF FEZOLINETANT, INTERMEDIATE THEREOF, AND PREPARATION METHOD THEREFOR

#5
20260007761
2026-01-08

Bioactive Conjugate, Preparation Method Therefor and Use Thereof

#6
20250368657
2025-12-04

METHODS FOR INHIBITING FASCIN

#7
20250289791
2025-09-18

FORMULATIONS

#8
20250221967
2025-07-10

COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER AND OTHER PROLIFERATIVE DISEASES

#9
20250136563
2025-05-01

THIADIAZOLONE DERIVATIVES USEFUL AS AMPK ACTIVATOR

#10
20250122152
2025-04-17

KAT6 Inhibitors

#11
20240383852
2024-11-21

ANTI-VIRAL COMPOUNDS

#12
20240317733
2024-09-26

CYCLOPROPANAMINE COMPOUND AND USE THEREOF

#13
20240158414
2024-05-16

BI-ARYL DIHYDROOROTATE DEHYDROGENASE INHIBITORS

#14
20240158402
2024-05-16

METHODS FOR INHIBITING FASCIN

#15
20240140921
2024-05-02

Formulations

#16
20240124466
2024-04-18

COMPOUNDS AND USE THEREOF FOR TREATMENT OF NEURODEGENERATIVE, DEGENERATIVE AND METABOLIC DISORDERS

#17
20240043395
2024-02-08

COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING

#18
20230382930
2023-11-30

THIADIAZOLONE DERIVATIVES AND THEIR USE AS AMPK AGONISTS FOR THE TREATMENT OF DIABETES AND RELATED DISORDERS

#19
20230247997
2023-08-10

NEMATICIDE COMPOUNDS, COMPOSITIONS, AND METHODS OF THEIR MAKING AND USE

#20
20230219912
2023-07-13

HALOGENATED BENZOTHIADIAZINES FOR THE TREATMENT OF CANCER

#21
20230150931
2023-05-18

FABP4/5 INHIBITORS, METHODS OF USE AND METHODS OF MAKING

#22
20230142274
2023-05-11

SUBSTITUTED ARYL COMPOUND

#23
20230125667
2023-04-27

NOVEL TDZD ANALOGS AS AGENTS THAT DELAY, PREVENT, OR REVERSE AGE-ASSOCIATED DISEASES AND AS ANTI-CANCER AND ANTILEUKEMIC AGENTS

#24
20230113588
2023-04-13

METABOTROPIC GLUTAMATE RECEPTOR NEGATIVE ALLOSTERIC MODULATORS (NAMS) AND USES THEREOF

#25
20230096218
2023-03-30

NEW FORMULATIONS

#26
20230083885
2023-03-16

MODULATORS OF INTEGRATED STRESS RESPONSE PATHWAY

#27
20230061429
2023-03-02

Bicyclic compounds

#28
20230024283
2023-01-26

HERBICIDAL COMPOUNDS

#29
20220304984
2022-09-29

AMINO ACID TRANSPORT INHIBITORS AND THE USES THEREOF

#30
20220274938
2022-09-01

5-[(1S)-1-(4-BROMOPHENOXY)ETHYL]-2H-TETRAZOLE DERIVATIVES AND RELATED COMPOUNDS AS CLC-1 ION CHANNEL INHIBITORS FOR TREATING NEUROMUSCULAR DISORDERS

#31
20220267287
2022-08-25

Formulations

#32
20220056000
2022-02-24

Synthesis of 3-methyl-1,2,4-thiadiazole-5-carbohydrazide or of the methyl-deuterated form thereof

#33
20220000844
2022-01-06

4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels

#34
20210332051
2021-10-28

Methods for inhibiting fascin

#35
20210276964
2021-09-09

COMPOSITIONS AND METHODS FOR TREATING CANCERS

#36
20210238127
2021-08-05

FTO Inhibitors

#37
20210179603
2021-06-17

CYCLOPROPANAMINE COMPOUND AND USE THEREOF

#38
20210171537
2021-06-10

Benzenesulfonamide compouds and their use as therapeutic agents

#39
20210163467
2021-06-03

Morpholine derivates as inhibitors of Vps34

#40
20210139467
2021-05-13

MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE

#41
20200354354
2020-11-12

Benzenesulfonamide compounds and their use as therapeutic agents

#42
20200347021
2020-11-05

Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof

#43
20200299282
2020-09-24

COMPOUNDS AND METHODS FOR TREATING CANCER

#44
20200148628
2020-05-14

FTO inhibitors

#45
20200115374
2020-04-16

Modulators of indoleamine 2,3-dioxygenase

#46
20200115354
2020-04-16

THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF

#47
20200069646
2020-03-05

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

#48
20200055831
2020-02-20

Heterocyclic P2X7 antagonists

#49
20200048240
2020-02-13

Acyl sulfonamide NaV1.7 inhibitors

#50
20200017506
2020-01-16

Methods for inhibiting fascin

#51
20200017488
2020-01-16

Heterocyclic inhibitors of the sodium channel

#52
20190382358
2019-12-19

HETEROCYCLIC COMPOUNDS AS PESTICIDES

#53
20190337910
2019-11-07

ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS

#54
20190315735
2019-10-17

Cyclopropanamine compound and use thereof

#55
20190233406
2019-08-01

HYDROXYALKYLAMINE- and HYDROXYCYCLOALKYLAMINE-SUBSTITUTED DIAMINE-ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS

#56
20190194184
2019-06-27

Benzenesulfonamide compounds and their use as therapeutic agents

#57
20190194152
2019-06-27

Compositions and methods for treating cancers

#58
20190169142
2019-06-06

Sulfonamides as GPR40- and GPR120-agonists

#59
20190119223
2019-04-25

Modulators of indoleamine 2,3-dioxygenase

#60
20190111031
2019-04-18

Analgesic compounds

#61
20190092738
2019-03-28

N1-phenylpropane-1,2-diamine compounds with selective activity in voltage-gated sodium channels

#62
20190040023
2019-02-07

Modulators of indoleamine 2,3-dioxygenase

#63
20190016715
2019-01-17

Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof

#64
20180338981
2018-11-29

Process for preparing ceftolozane from 7-aminocephalosporanic acid (7-ACA)

#65
20180297965
2018-10-18

Compositions and methods for treating cancers

#66
20180290988
2018-10-11

Modulators of indoleamine 2,3-dioxygenase

#67
20180271097
2018-09-27

HETEROCYCLIC TRIFLUOROALKENYL COMPOUNDS HAVING A NEMATOCIDAL ACTIVITY, THEIR AGRONOMIC COMPOSITIONS AND USE THEREOF

#68
20180213782
2018-08-02

Heterocyclic compounds as pesticides

#69
20180208552
2018-07-26

Urea derivative or pharmacologically acceptable salt thereof

#70
20180203175
2018-07-19

TRIAZOLE COMPOUND

#71
20180194710
2018-07-12

Metabotropic glutamate receptor positive allosteric modulators (PAMS) and uses thereof

#72
20180170876
2018-06-21

Histone deacetylase inhibitors

#73
20180162868
2018-06-14

BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

#74
20180162853
2018-06-14

Cyclopropanamine compound and use thereof

#75
20180127406
2018-05-10

Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use

#76
20180118665
2018-05-03

FTO inhibitors

#77
20180105504
2018-04-19

Therapeutic compounds and methods of use thereof

#78
20180072708
2018-03-15

Oxadiazole derivative and pharmaceutical containing same

#79
20180037744
2018-02-08

Particles for electrophoretic displays

#80
20180030007
2018-02-01

Allosteric modulators of nicotinic acetylcholine receptors

#81
20180021346
2018-01-25

GLP-1 receptor modulators

#82
20180002298
2018-01-04

COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

#83
20170369459
2017-12-28

Thiadiazolyl-oximinoacetic acid derivative compounds

#84
20170334902
2017-11-23

Benzenesulfonamide compounds and their use as therapeutic agents

#85
20170313674
2017-11-02

Benzylhydroxide derivatives, preparation thereof and therapeutic use thereof

#86
20170305943
2017-10-26

COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS

#87
20170275275
2017-09-28

BENZENESULFONAMIDES USEFUL AS SODIUM CHANNEL INHIBITORS

#88
20170275260
2017-09-28

Allosteric modulators of nicotinic acetylcholine receptors

#89
20170217951
2017-08-03

Metabotropic glutamate receptor negative allosteric modulators (NAMS) and uses thereof

#90
20170190698
2017-07-06

Enzyme interacting agents

#91
20170174674
2017-06-22

Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channels

#92
20170152262
2017-06-01

Vinylogous thioester compounds and methods of use

#93
20170145003
2017-05-25

HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL

#94
20170129906
2017-05-11

Reactions of thiadiazolyl-oximinoacetic acid derivative compounds

#95
20170121297
2017-05-04

Compositions and methods for treating cancers

#96
20170057914
2017-03-02

N-arylamidine-substituted trifluoroethyl sulfide derivatives as acaricides and insecticides

#97
20170036987
2017-02-09

Metabotropic glutamate receptor positive allosteric modulators (PAMS) and uses thereof

#98
20170029417
2017-02-02

Cyclopropanamine compound and use thereof

#99
20170022174
2017-01-26

COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

#100
20170001994
2017-01-05

Cyclopropanamine compound and use thereof

#101
20170001984
2017-01-05

Cycloalkane derivatives

#102
20160331782
2016-11-17

Heteroaryl disulfide compounds as allosteric effectors for increasing the oxygen-binding affinity of hemoglobin

#103
20160311814
2016-10-27

Cyclopropanamine compound and use thereof

#104
20160311808
2016-10-27

Cyclopropanamine compound and use thereof

#105
20160257660
2016-09-08

Thiadiazolidinediones as GSK-3 inhibitors

#106
20160237060
2016-08-18

3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals

#107
20160228450
2016-08-11

GLP-1 receptor modulators

#108
20160221974
2016-08-04

SODIUM CHANNEL MODULATORS FOR THE TREATMENT OF PAIN AND DIABETES

#109
20160152621
2016-06-02

Aryl lactam kinase inhibitors

#110
20160130239
2016-05-12

Sodium channel modulators for the treatment of pain and diabetes

#111
20160128993
2016-05-12

1,2,4-thiazolidin-3-one derivatives and their use in the treatment of cancer

#112
20160101102
2016-04-14

Piperazine thiazole derivatives useful in the treatment of tauopathies such as Alzheimer's disease

#113
20160096804
2016-04-07

Histone deacetylase inhibitors

#114
20160046617
2016-02-18

Sodium channel modulators for the treatment of pain

#115
20150376177
2015-12-31

Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use

#116
20150338563
2015-11-26

Resin composition

#117
20150336916
2015-11-26

Epoxyeicosatrienoic acid analogs and methods of making and using the same

#118
20150291577
2015-10-15

Cyclopropanamine compound and use thereof

#119
20150274681
2015-10-01

Compounds for the treatment of neurodegenerative diseases

#120
20150225388
2015-08-13

Compounds for use in the treatment of mycobacterial infections

#121
20150133675
2015-05-14

PDE10 inhibitors and related compositions and methods

#122
20150105581
2015-04-16

Cyclopentylacrylamide derivative

#123
20150038538
2015-02-05

Thiadiazolidinediones as GSK-3 inhibitors

#124
20150038416
2015-02-05

GLP-1 receptor modulators

#125
20150018551
2015-01-15

Cycloalkane derivatives

#126
20150011604
2015-01-08

Compounds for the treatment of neurodegenerative diseases

#127
20140341850
2014-11-20

Haloalkyl heteroaryl benzamide compounds

#128
20140330011
2014-11-06

Certain heterocycles, compositions thereof, and methods for their use

#129
20140323442
2014-10-30

Small molecule modulators of pRb inactivation

#130
20140315933
2014-10-23

CHEMICAL COMPOUNDS

#131
20140315898
2014-10-23

N-arylamidine-substituted trifluoroethyl sulfide derivatives as acaricides and insecticides

#132
20140296245
2014-10-02

Benzenesulfonamide compounds and their use as therapeutic agents

#133
20140275224
2014-09-18

CYTOSINE DEAMINASE MODULATORS FOR ENHANCEMENT OF DNA TRANSFECTION

#134
20140237735
2014-08-28

Zwitterionic azo dyestuffs for coloring keratin-including fibres

#135
20140206699
2014-07-24

Piperazine thiazole derivatives useful in the treatment of tauopathies such as alzheimer's disease

#136
20140155597
2014-06-05

Amidine compound or salt thereof

#137
20140135332
2014-05-15

Aromatic amides and uses thereof

#138
20140128404
2014-05-08

1, 2, 4-thiadiazol-5-ylpiperazine derivatives useful in the treatment of neurodegenerative diseases

#139
20140113884
2014-04-24

Epoxyeicosatrienoic acid analogs and methods of making and using the same

#140
20140080843
2014-03-20

Methods for inhibiting fascin

#141
20140051862
2014-02-20

5-membered ring heteroaromatic derivatives having NPY Y5 receptor antagonistic activity

#142
20140045862
2014-02-13

Cycloalkane derivatives

#143
20130338202
2013-12-19

Compounds for the treatment of neurodegenerative diseases

#144
20130338111
2013-12-19

Sulfonamide derivatives

#145
20130324537
2013-12-05

Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors

#146
20130225587
2013-08-29

Compound for increasing kinase active and application thereof

#147
20130150339
2013-06-13

Bicyclic aryl and heteroaryl sodium channel inhibitors

#148
20130109696
2013-05-02

N-sulfonylbenzamide compounds

#149
20130072471
2013-03-21

Inhibitors of ion channels

#150
20130060025
2013-03-07

Certain heterocycles, compositions thereof, and methods for their use

#151
20130053416
2013-02-28

3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals

#152
20130023498
2013-01-24

MicroRNA Modulators and Method for Identifying and Using the Same

#153
20120289698
2012-11-15

Certain heterocycles, compositions thereof, and methods for their use

#154
20120277273
2012-11-01

Small molecule inhibitors of RGS proteins

#155
20120277208
2012-11-01

BENZAMIDE COMPOUND

#156
20120225879
2012-09-06

Substituted 5-imino-1,2,4-thiadiazoles that can be used to treat neurodegenerative diseases

#157
20120183537
2012-07-19

1,2,4-thiazoloidin-3-one derivatives and their use in the treatment of cancer

#158
20120165339
2012-06-28

CYCLOPROPANE DERIVATIVES

#159
20120149679
2012-06-14

Sulfonamide derivatives

#160
20120142700
2012-06-07

Microbiocidal heterocycles

#161
20120115841
2012-05-10

Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists

#162
20120101136
2012-04-26

5-MEMBERED HETEROARYL DERIVATIVES USED AS SPHINGOSINE 1- PHOSPHATE RECEPTOR AGONISTS

#163
20120101134
2012-04-26

5-MEMBERED HETEROARYL DERIVATIVES USED AS SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONISTS

#164
20120071663
2012-03-22

Preparation of N'-(4--2,5-dimethylphenyl)-N- ethyl-N-methylimidoformamide

#165
20120046324
2012-02-23

Small molecule inhibitors of kynurenine-3-monooxygenase

#166
20120015957
2012-01-19

PIPERAZINYL DERIVATIVES USEFUL AS MODULATORS OF THE NEUROPEPTIDE Y2 RECEPTOR

#167
20110301150
2011-12-08

Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating Parkinson's disease using the same

#168
20110263628
2011-10-27

N-hydroxyamide derivatives and use thereof

#169
20110237589
2011-09-29

Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors

#170
20110230477
2011-09-22

COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING METABOLIC DISORDERS

#171
20110224202
2011-09-15

PDE10 inhibitors and related compositions and methods

#172
20110177943
2011-07-21

Benzyl-Substituted Thiadiazolyloxyphenylamidinium Salts

#173
20110160211
2011-06-30

Cyclopentylacrylamide derivative

#174
20110152080
2011-06-23

Thiadiazolyloxyphenylamidines and use thereof as fungicides

#175
20110143937
2011-06-16

Thiadiazolyloxyphenylamidines and use thereof as fungicides

#176
20110124696
2011-05-26

Sulfone compounds which modulate the CB2 receptor

#177
20110086893
2011-04-14

OXA- AND THIADIAZOLES AND THEIR USE AS METALLOPROTEINASE INHIBITORS

#178
20110071127
2011-03-24

Compounds which modulate the CB2 receptor

#179
20110060019
2011-03-10

Heteroaryl-ureas and their use as glucokinase activators

#180
20110059984
2011-03-10

Heterocycles useful as modulators of ion channels

#181
20100298388
2010-11-25

Substituted benzamidines as antibacterial agents

#182
20100292274
2010-11-18

Haloalkyl heteroaryl benzamide compounds

#183
20100286171
2010-11-11

Substituted pyrazine compounds

#184
20100286169
2010-11-11

Antibacterial sulfone and sulfoxide substituted heterocyclic urea compounds

#185
20100285957
2010-11-11

THIAZOLYLOXYPHENYLAMIDINES OR THIADIAZOLYLOXYPHENYLAMIDINES AND THEIR USE AS FUNGICIDES

#186
20100280079
2010-11-04

1,2,4-thiadiazolium derivatives as melanocortin receptor modulators

#187
20100274051
2010-10-28

Inflammatory cytokine release inhibitor

#188
20100273837
2010-10-28

Antibacterial agents

#189
20100222594
2010-09-02

Compound, composition and thin film

#190
20100204472
2010-08-12

Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation

#191
20100204288
2010-08-12

Heteroaryl-ureas and their use as glucokinase activators

#192
20100204230
2010-08-12

PIPERAZINE DERIVATIVES FOR TREATMENT OF AD AND RELATED CONDITIONS

#193
20100197655
2010-08-05

Sulfonamide derivatives

#194
20100160392
2010-06-24

Histone deacetylase inhibitors

#195
20100144709
2010-06-10

Thiadiazole derivatives for the treatment of neuro-degenerative diseases

#196
20100113276
2010-05-06

USE OF N2-PHENYLAMIDINES AS HERBICIDES

#197
20100105553
2010-04-29

Thiadiazolyl oxyphenyl amidines and the use thereof as a fungicide

#198
20100099671
2010-04-22

Glucokinase activator

#199
20100099662
2010-04-22

Hydrazone derivative

#200
20100063051
2010-03-11

Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

#201
20100035943
2010-02-11

Oxa-and thiadiazoles and their use as metalloproteinase inhibitors

#202
20100016383
2010-01-21

4-(3,3-DIHALO-ALLYLOXY)PHENOL DERIVATIVES HAVING PESTICIDAL PROPERTIES

#203
20100016304
2010-01-21

Glucokinase activator

#204
20100004298
2010-01-07

P-38 INHIBITORS

#205
20090325961
2009-12-31

Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

#206
20090312352
2009-12-17

COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASE CAUSED BY YERSINIA SPP INFECTION

#207
20090306358
2009-12-10

Sulfur transfer reagents for oligonucleotide synthesis

#208
20090270367
2009-10-29

Substituted hydroxyethylamine aspartyl protease inhibitors

#209
20090253676
2009-10-08

Heteroaryl Benzamide Derivatives for Use as GLK Activators in the Treatment of Diabetes

#210
20090233971
2009-09-17

GSK-3 inhibitors

#211
20090216013
2009-08-27

Heteroaryl-ureas and their use as glucokinase activators

#212
20090203751
2009-08-13

1,2,4-thiadiazolium derivatives as melanocortin receptor modulators

#213
20090192122
2009-07-30

INFLAMMATORY CYTOKINE RELEASE INHIBITOR

#214
20090149425
2009-06-11

Malononitrile compound as pesticides

#215
20090143358
2009-06-04

Heterocyclic sulfonamides as inhibitors of ion channels

#216
20090131489
2009-05-21

4-((PHENOXYALKYL)THIO)-PHENOXYACETIC ACIDS AND ANALOGS

#217
20090106915
2009-04-30

Coloring keratin fibers with metal complexes

#218
20090042961
2009-02-12

OXIME DERIVATIVE SUBSTITUTED HYDROXYETHYLAMINE ASPARTYL PROTEASE INHIBITORS

#219
20090018056
2009-01-15

Heteroarylcarbamoylbenzene derivatives

#220
20080318956
2008-12-25

INFLAMMATORY CYTOKINE RELEASE INHIBITOR

#221
20080318936
2008-12-25

Substituted 5-phenyl-3,6-dihydro-2-oxo-6H-1,3,4-thiadiazines

#222
20080312226
2008-12-18

Amide compound

#223
20080255196
2008-10-16

Pesticide thiazolyloxy substituted phenylamidine derivatives

#224
20080255147
2008-10-16

Heterocycles useful as modulators of ion channels

#225
20080249071
2008-10-09

INFLAMMATORY CYTOKINE RELEASE INHIBITOR

#226
20080242656
2008-10-02

N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof

#227
20080227833
2008-09-18

OXA- AND THIADIAZOLES AND THEIR USE AS METALLOPROTEINASE INHIBITORS

#228
20080153886
2008-06-26

Use Of Heterocyclic Compounds As Neurogenic Agents

#229
20080146625
2008-06-19

Oxime glucokinase activators

#230
20080139565
2008-06-12

Anthranilic Acid Derivatives and Their Use in Treatment of Diseases of Lipid Metabolism, in Particular Dyslipidaemia

#231
20080070937
2008-03-20

Small molecule inhibitors of kynurenine-3-monooxygenase

#232
20080064879
2008-03-13

Compound, composition and thin film

#233
20080058333
2008-03-06

CYCLOALKYL KETOAMIDES DERIVATIVES USEFUL AS CATHEPSIN K INHIBITORS

#234
20080051416
2008-02-28

Novel Compounds

#235
20080039464
2008-02-14

Compounds which modulate the CB2 receptor

#236
20080033012
2008-02-07

Enzyme inhibitors

#237
20080021028
2008-01-24

N-hydroxyamide derivatives and use thereof

#238
20080015203
2008-01-17

Heteroaryl benzamide derivatives as GLK activators

#239
20070299074
2007-12-27

Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors

#240
20070293510
2007-12-20

Thiadiazole compounds and use thereof

#241
20070238733
2007-10-11

Compositions useful as inhibitors of voltage-gated sodium channels

#242
20070185056
2007-08-09

Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

#243
20070179134
2007-08-02

Urea derivatives, processes for their preparation, their use as medicaments, and pharmaceutical compositions containing them

#244
20070155748
2007-07-05

N-sulfonyl-α-amino-acid derivatives

#245
20070149584
2007-06-28

Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors

#246
20070105959
2007-05-10

Cynnamyl alcohol derivative compounds and drugs containing the compounds as active ingredient

#247
20070066614
2007-03-22

Ihibitors of 11-beta-hydroxy steroid dehydrogenase type 1

#248
20070054897
2007-03-08

Heteroaryl-ureas and their use as glucokinase activators

#249
20070049594
2007-03-01

Novel compounds and compositions as cathepsin inhibitors

#250
20070015918
2007-01-18

Derivatives of 1,3-diones having a herbicidal activity

#251
20070004741
2007-01-04

N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase

#252
20070004722
2007-01-04

1,2,4-Thiadiazole compounds and pests controlling composition containing the same

#253
20060276518
2006-12-07

Aryl and heteroaryl compounds and methods to modulate coagulation

#254
20060167266
2006-07-27

1,2,4-thiadiazole compounds and use thereof

#255
20060167053
2006-07-27

Heteroarylcarbamoylbenzene derivative

#256
20060167009
2006-07-27

Monocyclic substituted phenyl methanones

#257
20060135581
2006-06-22

Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors

#258
20060135572
2006-06-22

CaSR antagonist

#259
20060128772
2006-06-15

1,2,4-thiadiazole derivatives as melanocortin receptor modulators

#260
20060089357
2006-04-27

Novel compounds and compositions as cathepsin inhibitors

#261
20060084680
2006-04-20

Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation

#262
20060074246
2006-04-06

4-((Phenoxyalkyl)thio)-phenoxyacetic acids and analogs

#263
20060063820
2006-03-23

2,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties

#264
20060052422
2006-03-09

1,2,4-thiadiazole compounds and arthropod controlling composition containing the same

#265
20060030604
2006-02-09

Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators

#266
20060014962
2006-01-19

Thiadiazole compound and use thereof

#267
20060014743
2006-01-19

Methods of preventing bacterial infections with florfenicol-type antibiotics

#268
20050288186
2005-12-29

4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties

#269
20050239836
2005-10-27

Substituted hydroxyethylamine aspartyl protease inhibitors

#270
20050239790
2005-10-27

Substituted hydroxyethylamine aspartyl protease inhibitors

#271
20050234125
2005-10-20

Alpha-sulfonylamino-acetonitriles

#272
20050222220
2005-10-06

GSK-3 inhibitors

#273
20050222189
2005-10-06

Oxa-and thiadiazoles and their use as metalloproteinase inhibitors

#274
20050222146
2005-10-06

N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof

#275
20050215578
2005-09-29

Thiadiazole compounds and use thereof

#276
20050096362
2005-05-05

4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs

#277
20050054819
2005-03-10

Cycloalkyl ketoamides derivatives useful as cathepsin K inhibitors

#278
20050020679
2005-01-27

Inhibitors of the anandamide transporter

#279
20050014803
2005-01-20

Enzyme inhibitors

#280
20050009821
2005-01-13

Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1

#281
20050004232
2005-01-06

Acyl sulfonamides as inhibitors of HIV integrase

#282
16821294
2020-10-27

Benzenesulfonamide compounds and their use as therapeutic agents